Warning! GuruFocus detected
3 Severe warning signs
with SCS.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Stem Cells Spin SA
NAICS : 541711
SIC : 8731
ISIN : PLSTCLS00013
Compare
Compare
Traded in other countries / regions
SCS.Poland IPO Date
2011-10-25Description
Stem Cells Spin SA is a biotechnology company. The company is engaged in the development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets, as well as applications for the human and veterinary medical industry. Its products include NHAC Biocervin MIC-1, Revitacell, PRS MIC-1 and Velvetyna.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1 | |||||
| Equity-to-Asset | 0.58 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.74 | |||||
| Beneish M-Score | -2.3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -57.5 | |||||
| 3-Year EBITDA Growth Rate | 8.1 | |||||
| 3-Year EPS without NRI Growth Rate | -58.7 | |||||
| 3-Year FCF Growth Rate | -60.3 | |||||
| 3-Year Book Growth Rate | -3 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.49 | |||||
| 9-Day RSI | 41.03 | |||||
| 14-Day RSI | 41.52 | |||||
| 3-1 Month Momentum % | 5.26 | |||||
| 6-1 Month Momentum % | -4.76 | |||||
| 12-1 Month Momentum % | -57.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.99 | |||||
| Quick Ratio | 0.52 | |||||
| Cash Ratio | 0.03 | |||||
| Days Inventory | 26727.13 | |||||
| Days Sales Outstanding | 281.19 | |||||
| Days Payable | 1606 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 1.45 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 85.19 | |||||
| Operating Margin % | -883.33 | |||||
| Net Margin % | -883.33 | |||||
| FCF Margin % | 116.67 | |||||
| ROE % | -6.65 | |||||
| ROA % | -3.71 | |||||
| ROIC % | -3.74 | |||||
| 3-Year ROIIC % | 7.1 | |||||
| ROC (Joel Greenblatt) % | -90.41 | |||||
| ROCE % | -3.74 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 20.79 | |||||
| PS Ratio | 178 | |||||
| PB Ratio | 1.07 | |||||
| Price-to-Tangible-Book | 17.8 | |||||
| Price-to-Free-Cash-Flow | 178 | |||||
| Price-to-Operating-Cash-Flow | 178 | |||||
| EV-to-EBIT | -15.43 | |||||
| EV-to-EBITDA | 10.01 | |||||
| EV-to-Revenue | 136.26 | |||||
| EV-to-FCF | 116.79 | |||||
| Price-to-GF-Value | 3.56 | |||||
| Price-to-Projected-FCF | 1.11 | |||||
| Price-to-Median-PS-Value | 4.45 | |||||
| Earnings Yield (Greenblatt) % | -6.48 | |||||
| FCF Yield % | 0.86 | |||||
| Forward Rate of Return (Yacktman) % | -6.04 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Stem Cells Spin SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil zł) | 0.054 | ||
| EPS (TTM) (zł) | -0.011 | ||
| Beta | 0.34 | ||
| 3-Year Sharpe Ratio | -0.57 | ||
| 3-Year Sortino Ratio | -0.71 | ||
| Volatility % | 45.15 | ||
| 14-Day RSI | 41.52 | ||
| 14-Day ATR (zł) | 0.012272 | ||
| 20-Day SMA (zł) | 0.189 | ||
| 12-1 Month Momentum % | -57.45 | ||
| 52-Week Range (zł) | 0.163 - 0.55 | ||
| Shares Outstanding (Mil) | 41.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Stem Cells Spin SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Stem Cells Spin SA Stock Events
| Event | Date | Price (zł) | ||
|---|---|---|---|---|
| No Event Data | ||||
Stem Cells Spin SA Frequently Asked Questions
What is Stem Cells Spin SA(WAR:SCS)'s stock price today?
The current price of WAR:SCS is zł0.18. The 52 week high of WAR:SCS is zł0.55 and 52 week low is zł0.16.
When is next earnings date of Stem Cells Spin SA(WAR:SCS)?
The next earnings date of Stem Cells Spin SA(WAR:SCS) is .
Does Stem Cells Spin SA(WAR:SCS) pay dividends? If so, how much?
Stem Cells Spin SA(WAR:SCS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers